The National Oncology Alliance (NOA) is a
cancer advocacy initiative with more than 100 members in four pillars:
patients, patient groups, clinicians and the pharmaceutical industry.
Collectively all are determined to ensure patients living with cancer have
access to the care and treatment they deserve. NOA’s work is directed by a
steering committee, co-chaired by Professor John Zalcberg OAM and Rare Cancers
Australia CEO Richard Vines.
For more information please go to